Cardiometabolic Risk, Part 1: Chemotherapy and Radiotherapy – Old Foes Still Threatening Cancer Survivors?

An integrated approach to cardioprotection in lymphomas

“…Early detection of cardiac dysfunction enables timely initiation of heart failure treatment, which has been shown to increase the chance of complete recovery 14 , whereas delay is likely to result in the transition from asymptomatic left ventricular dysfunction to clinically overt heart failure with progressive and irreversible heart damage. Strategies for cardioprotection alongside baseline risk stratification, stringent surveillance screening and early treatment of cardiotoxicity are therefore of outmost importance for HL and NHL patients who have a relatively good prognosis and long disease-specific survival 15 .…”